Peringkat dalam Saham
#39900
Abpro Holdings, Inc. is a biotechnology firm dedicated to creating... Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-100, designed to target breast, gastric, and colorectal cancers, and ABP-201, intended for the treatment of vascular diseases affecting the eye. The company has established strategic alliances with Abpro Bio Co. Ltd and NJCTTQ. Originally known as Abpro Corporation, the company officially changed its name to Abpro Holdings, Inc. in November 2024. Incorporated in 2004, Abpro Holdings, Inc. operates from its headquarters in Woburn, Massachusetts.
Harga Saham
$0.158
Terakhir disinkronkan: 2026-04-06
Kapitalisasi Pasar
$302.92K
Perubahan (1 hari)
16.18%
Perubahan (1 tahun)
-97.91%
Perdagangan Abpro Corporation (ABP)
Harga ABP dengan kapitalisasi pasar B
Kapitalisasi pasar dari Abpro Corporation(ABP)
Kapitalisasi Pasar: $302.92K
Per August 2026, Abpro Corporation memiliki kapitalisasi pasar sebesar $302.92K. Ini menjadikan Abpro Corporation sebagai perusahaan 39900th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Abpro Corporation dari 2024 hingga 2026
ABP dibandingkan dengan 5 teratas stocks paling populer
| Harga ABP |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.470T
|
+1,805,575,590.80%
|
|
|
|
|
$4.467T
|
+1,474,646,479.12%
|
|
|
|
|
$4.174T
|
+1,378,026,865.56%
|
|
|
|
|
$3.700T
|
+1,221,450,398.25%
|
|
|
|
|
$2.854T
|
+942,260,836.96%
|
